Standard Gravure shooting

Last updated
Standard Gravure shooting
Location Louisville, Kentucky, U.S.
DateSeptember 14, 1989 (1989-09-14)
8:38 – 9:00 a.m. (EDT)
Attack type
 Mass murder, murder-suicide, mass shooting
Weapons Polytech AK-47S
SIG Sauer P226 pistol (9mm)
Deaths9 (including the perpetrator)
Injured12
PerpetratorJoseph Thomas Wesbecker; Eli Lilly and Company
Litigation1

The Standard Gravure shooting occurred on September 14, 1989, in Louisville, Kentucky, United States, when Joseph T. Wesbecker, a 47-year-old pressman, killed eight people and injured twelve at his former workplace, Standard Gravure, before committing suicide. The shooting is the deadliest mass shooting in Kentucky's history. [1] The murders resulted in a high-profile lawsuit against Eli Lilly and Company, manufacturers of the antidepressant drug Prozac, which Wesbecker had begun taking during the month prior to his shooting rampage. [2]

Contents

Background

Standard Gravure was a prominent printing company founded in 1922 by Robert Worth Bingham. [3] Reduced revenues led to an employee wage freeze in 1982, and in 1986 the Bingham family sold the company. [4] Standard Gravure's customers were retailers, many of which were in the process of going out of business, and at the same time, paper shortages were occurring in the marketplace. [2]

Shooting

On September 14, 1989, Wesbecker, who was nicknamed "Rocky" by his colleagues, parked his car in front of the main entrance of Standard Gravure and entered the plant at 8:38 a.m., carrying a Polytech AK-47S, (a Chinese-made semiautomatic AK-47 derivative), a SIG Sauer P226 9mm pistol, and a duffel bag containing two MAC-11s, a snubnosed .38 caliber Smith & Wesson Model 12 Airweight revolver, a bayonet, and several hundred rounds of ammunition. [2]

He took the elevator to the executive reception area on the third floor and, as soon as the doors opened, he fired at receptionists Sharon Needy, whom he killed, and Angela Bowman, who he paralyzed with a shot in the back. Searching for Standard Gravure's President, Michael Shea, and other supervisors and managers of the plant, Wesbecker calmly walked through the hallways, deliberately shooting at people. He killed James Husband and injured Forrest Conrad, Paula Warman and John Stein, a bindery supervisor whom he shot in the head and abdomen. Wesbecker then headed down the stairs to the pressroom, where he killed Paul Sallee and wounded Stanley Hatfield and David Sadenfaden, two electricians from Marine Electric who were working on a broken machine. [2]

Leaving his duffel bag under a stairwell, Wesbecker walked down to the basement, where he encountered pressman John Tingle who, alerted by the loud noises, went to see what was going on. Tingle greeted his colleague, asking him what was happening. Wesbecker replied: "Hi John... I told them I'd be back. Get away from me." After Tingle moved out of his way, Wesbecker continued his path through the basement, shooting Richard Barger in the back, killing him. According to witnesses, Wesbecker approached Barger's body and apologized, having apparently killed him accidentally, as he could not see at whom he was shooting. [2]

Back on the pressroom floor, he shot at anyone in his way, killing James Wible and Lloyd White, then entered the breakroom, where he emptied his magazine, hitting all seven workers present and killing William Ganote with a shot to the head. Wesbecker then reloaded and resumed firing, fatally wounding Kenneth Fentress.

Wesbecker then returned to the pressroom, where he pulled out his SIG Sauer, put it under his chin, and shot himself, ending a shooting spree that had lasted for about half an hour. He had fired about 40 rounds. [5]

Victims

Eight people were killed in the attack and twelve were wounded. One person had suffered a heart attack. [5]

  • Richard O. Barger, 54
  • Kenneth Fentress, 45
  • William Ganote, 46
  • James G. Husband, 47
  • Sharon L. L. Needy, 49
  • Paul Sallee, 59
  • Lloyd White, 42
  • James F. Wible Sr., 56

Investigation

When police searched Wesbecker's house, they recovered a shotgun, a Colt 9-millimeter revolver, a .32 revolver, and a starter's pistol. They found Wesbecker's will, as well as an issue of Time Magazine , on the kitchen table. The magazine featured an article about Patrick Purdy, the perpetrator of the Cleveland Elementary School shooting earlier that year. [6] [7]

Perpetrator

Photo of Joseph Wesbecker from his driver's licence. Joseph Wesbecker.jpg
Photo of Joseph Wesbecker from his driver's licence.

Joseph Thomas Wesbecker (April 27, 1942 – September 14, 1989) was identified as the shooter. When he was 13 months old, his father, a construction worker, died in a fall. [4] After his father's death, he was raised as an only child by his mother Martha, herself only 16 years old at that time, and her family, though he was often passed from place to place during his early childhood, and at one time deposited in an orphanage for almost a year. [6] [4] [8] His grandfather, to whom he felt closely attached, died when he was four. [6]

As Wesbecker was a poor student, he dropped out of high school in the ninth grade, but later managed to earn his G.E.D. [6] [4] In 1960 he started to work as a pressman at a printing plant and married one year later. With his wife he had two sons, James and Joseph. [4] In 1971, he started working at Standard Gravure, where he soon earned a reputation as a determined, hard-working, loyal and reliable worker. [6] [4]

The year 1978 marked the beginning of the downward slope of Wesbecker's life. His marriage ended in divorce and a bitter battle over custody and support for his two sons ensued. [4] It was also the year he admitted himself for the first time to a hospital to seek psychiatric treatment. [9] In 1983, Wesbecker married again; Wesbecker's second marriage also ended in divorce after one year. [4] As a consequence he became increasingly reclusive and suicidal, separated from most of his family members and lived an overall lonely life, in whose center his work remained. [6]

After the selling of Standard Gravure and the subsequent management change in 1986, Wesbecker was assigned to a mechanical folder. He soon complained about stress and undue pressure and asked to be placed back at his old job. His request was declined, and he grew increasingly hostile against the new management, became wary of conspiracies aimed to harass him, and began to complain about policy changes at the company. [6] [4] He started complaining that exposure to toluene at work caused him memory loss, dizziness and "blackout spells". [9]

The hostility culminated in May 1987, when Wesbecker filed a complaint with the Jefferson County Human Relations Commission, charging that he was being harassed and discriminated against for his psychological state and being deliberately put under stressful conditions. A subsequent examination confirmed that Wesbecker suffered from depression and manic depression, substantiating his claim of mental illness. He was prescribed Prozac. [6]

In August 1988, Wesbecker stopped working and was finally put on a long-term disability leave in February 1989, though there was also an agreement to re-employ him as soon as he recovered sufficiently. [6] [4] Between August 1988 and May 1989, Wesbecker bought several weapons, among them the AK-47 and pistol he later used in the shooting. [7] Shortly before the shooting at Standard Gravure, where he showed up the last time on September 13, Wesbecker presumably received a letter from the company, announcing the cancellation of his disability income. [6] [10]

Psychiatric history

Wesbecker had a long history of psychiatric illness and was treated for it in hospitals at least three times between 1978 and 1987. He was diagnosed as suffering from alternating episodes of deep depression and manic depression, was beset, among others, by confusion, anger and anxiety and made several attempts to commit suicide. [6] [9] Hospital records also suggested that Wesbecker posed a threat to himself and others. [9]

According to CBS's 60 Minutes , "In 1984, five years before he took Prozac, Wesbecker's medical records show that he had this conversation with a doctor. Have you ever felt like harming someone else? 'Yes,' Wesbecker said. Who? 'My foreman.' When? 'At work.' The same medical records show Wesbecker had already attempted suicide 12 to 15 times." [11]

In the years prior to the shooting, Wesbecker more than once threatened to "kill a bunch of people" or to bomb Standard Gravure and at one point considered hiring an assassin to kill several executives of the company. Apparently, he even discussed these things with his wife before their divorce. [6] When he left Standard Gravure in August 1988, he told other workers that he would come back to wipe out the place and get even with the company. Shortly before the shooting, he told one of his aunts that he was upset about things at work, and said they will get paid back, but as he said these things all the time, she didn't take the threat too seriously. [4]

One of the employees at Standard Gravure said after the shooting: "This guy's been talking about this for a year. He's been talking about guns and Soldier of Fortune magazine . He's paranoid, and he thought everyone was after him." [12] Three days prior to the shooting, on September 11, Wesbecker told his psychiatrist that a foreman had forced Wesbecker to perform oral sex on him in front of his co-workers to get off the folder. In his notes, the psychiatrist wrote "Prozac?" [13]

Lawsuit: Fentress v. Shea Communications

In August 1989, less than a month before the shooting, Wesbecker had started taking Prozac. The wounded and the families of those killed filed a lawsuit against the drug's manufacturer, Eli Lilly and Company, claiming that Wesbecker's use of Prozac contributed to his actions. The case went to jury trial.

One of Eli Lilly's defences was that the Food and Drug Administration (FDA) had approved Prozac, to which the plaintiffs countered that Eli Lilly had failed to give the FDA accurate information about testing of the drug, including tests by the Federal Health Agency (BGA) in the Federal Republic of Germany. Initially, trial judge excluded as irrelevant and unduly prejudicial evidence that Eli Lilly had in 1985 been found guilty of failing to report to the FDA adverse effects of Oraflex during testing, including deaths. [14] [15] [16] The FDA only became aware of Oraflex's adverse effects when, in August 1982, the British Committee on the Safety of Medicines telegrammed the FDA that it had received 3,500 reports of adverse side effects, including 61 deaths. [17] Eli Lilly and its chief medical officer pled guilty to multiple criminal violations of various federal statutes and withholding evidence adverse to the drug, including 11 deaths in the US, [17] from the FDA. [18]

Upon an application by the plaintiffs, the trial judge admitted the Oraflex evidence on the ground that Eli Lilly itself had adduced evidence that it had a reputation for reporting adverse incidents to the FDA, putting the matter in issue. The evidence was never led. The plaintiffs agreed not to do so in a secret agreement with Eli Lilly that was concealed from the trial judge, John W. Potter, in order that the trial could continue. The jury ruled in favor of Eli Lilly without having heard the Oraflex evidence. [18] Information about parties' agreement later emerged with the case proceeding to verdict without plaintiffs' strongest evidence in order to obtain a favorable verdict, thereby setting a misleading precedent deterring similar lawsuits in the future related to Prozac. How much was paid to the plaintiffs and other details of the settlement are unknown. [18]

When plaintiffs failed to appeal and noting that plaintiffs’ attorneys deliberately had withheld their strongest evidence (the Oraflex evidence) which he had ruled should be admitted Judge Potter suspected something was amiss, and accused Lilly of questionable ethics and trial fixing. With unanimous authorization from the Kentucky Supreme Court, Judge Potter successfully applied to have the court record show that the suit was indeed resolved by settled rather by jury verdict absolving Eli Lilly. [14] [19] [16]

Eli Lilly since has paid out an estimated $50m across 300 lawsuits arising from homicides, suicides and suicide attempts connected with Prozac use. [20]

See also

Related Research Articles

ImClone Systems LLC was a biopharmaceutical company dedicated to developing biologic medicines in the area of oncology. It was founded in 1984 and had its corporate headquarters in Bridgewater, New Jersey, and its research headquarters in New York City. On October 6, 2008, it accepted a $6.5 billion acquisition offer from Eli Lilly and Company, and became a fully-owned subsidiary of Eli Lilly and Company on November 24, 2008. Prior to the acquisition, it was traded on the NASDAQ stock exchange under the symbol IMCL. Imclone lost its separate identity in 2014 when its former ImClone research and manufacturing sites were renamed as Eli Lilly and Company.

<span class="mw-page-title-main">Duloxetine</span> Antidepressant medication used also for the treatment of anxiety and chronic pain

Duloxetine, sold under the brand name Cymbalta among others, is a medication used to treat major depressive disorder, generalized anxiety disorder, obsessive-compulsive disorder, fibromyalgia, neuropathic pain and central sensitization. It is taken by mouth.

<span class="mw-page-title-main">David Healy (psychiatrist)</span> Irish-born pharmacologist

David HealyFRCPsych, a professor of psychiatry at Bangor University in the United Kingdom, is a psychiatrist, psychopharmacologist, scientist and author. His main areas of research are the contribution of antidepressants to suicide, conflict of interest between pharmaceutical companies and academic medicine, and the history of pharmacology. Healy has written more than 150 peer-reviewed articles, 200 other articles, and 20 books, including The Antidepressant Era, The Creation of Psychopharmacology, The Psychopharmacologists Volumes 1–3, Let Them Eat Prozac and Mania: A Short History of Bipolar Disorder.

<span class="mw-page-title-main">Eli Lilly and Company</span> American pharmaceutical company

Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union Army veteran of the American Civil War for whom the company was later named.

<span class="mw-page-title-main">Peter Breggin</span> American psychiatrist

Peter Roger Breggin is an American psychiatrist and critic of shock treatment and psychiatric medication and COVID-19 response. In his books, he advocates replacing psychiatry's use of drugs and electroconvulsive therapy with psychotherapy, education, empathy, love, and broader human services.

Robert Ray Courtney is an American former pharmacist from Kansas City, Missouri. In 2002, after initially being caught diluting several doses of chemotherapy drugs, he pleaded guilty to intentionally diluting 98,000 prescriptions involving multiple types of drugs, which were given to 4,200 patients, and was sentenced to 30 years in federal prison.

Standard Gravure was a Louisville, Kentucky rotogravure printing company founded in 1922 by Robert Worth Bingham and owned by the Bingham family. For decades, it printed the weekly The Courier-Journal as well as rotogravure sections for other newspapers as well as Parade.

<span class="mw-page-title-main">Fluoxetine</span> SSRI antidepressant

Fluoxetine, sold under the brand name Prozac, among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used for the treatment of major depressive disorder, obsessive–compulsive disorder (OCD), anxiety, bulimia nervosa, panic disorder, and premenstrual dysphoric disorder. It is also approved for treatment of major depressive disorder in adolescents and children 8 years of age and over. It has also been used to treat premature ejaculation. Fluoxetine is taken by mouth.

<span class="mw-page-title-main">Indalpine</span> Discontinued SSRI antidepressant drug

Indalpine, sold under the brand name Upstène, is a selective serotonin reuptake inhibitor (SSRI) that was briefly marketed as an antidepressant for treatment of depression. It was marketed in France and a few other European countries.

Benoxaprofen, also known as benoxaphen, is a chemical compound with the formula C16H12ClNO3. It is a non-steroidal anti-inflammatory drug (NSAID) of the arylpropionic acid class, and was marketed under the brand name Opren in the United Kingdom and Europe by Eli Lilly and Company (commonly referred to as Lilly), and as Oraflex in the United States of America (USA). Lilly suspended sales of Oraflex in 1982 after reports from the British government and the United States Food and Drug Administration (US FDA) of adverse effects and deaths linked to the drug.

Challenge–dechallenge–rechallenge (CDR) is a medical testing protocol in which a medicine or drug is administered, withdrawn, then re-administered, while being monitored for adverse effects at each stage. The protocol is used when statistical testing is inappropriate due to an idiosyncratic reaction by a specific individual, or a lack of sufficient test subjects and unit of analysis is the individual. During the dechallenge (withdrawal) phase, the medication is allowed to wash out of the system in order to determine what effect the medication is having on an individual.

Klaus Schmiegel, is a German chemist best known for his work in organic chemistry, which led to the invention of Prozac, a widely used antidepressant.

<span class="mw-page-title-main">Citizens Commission on Human Rights</span> Scientology-related organization

The Citizens Commission on Human Rights International (CCHR) is an anti-psychiatry lobbying organization established in 1969 by the Church of Scientology and psychiatrist Thomas Szasz. Headquartered in Los Angeles, California, its stated mission is to "eradicate abuses committed under the guise of mental health and enact patient and consumer protections." It is regarded by most non-Scientologists as a Scientology front group whose purpose is to push the organization's anti-psychiatry agenda.

<span class="mw-page-title-main">Lasmiditan</span> Chemical compound

Lasmiditan, sold under the brand name Reyvow, is a medication used for the acute treatment of migraine with or without aura in adults. It is not useful for prevention. It is taken by mouth.

<span class="mw-page-title-main">Dapoxetine</span> Medication used to treat premature ejaculation

Dapoxetine, marketed as Priligy, among others, is a selective serotonin reuptake inhibitor (SSRI) used for the treatment of premature ejaculation (PE) in men 18–64 years old. Dapoxetine works by inhibiting the serotonin transporter, increasing serotonin's action at the postsynaptic cleft, and as a consequence promoting ejaculatory delay. As a member of the selective serotonin reuptake inhibitor (SSRI) family, dapoxetine was initially created as an antidepressant. However, unlike other SSRIs, dapoxetine is absorbed and eliminated rapidly in the body. Its fast-acting property makes it suitable for the treatment of PE, but not as an antidepressant.

<span class="mw-page-title-main">Baricitinib</span> Chemical compound

Baricitinib, sold under the brand name Olumiant among others, is an immunomodulatory medication used for the treatment of rheumatoid arthritis, alopecia areata, and COVID-19. It acts as an inhibitor of janus kinase (JAK), blocking the subtypes JAK1 and JAK2.

<span class="mw-page-title-main">Dulaglutide</span> Diabetes medication

Dulaglutide, sold under the brand name Trulicity among others, is a medication used for the treatment of type 2 diabetes in combination with diet and exercise. It is also approved in the United States for the reduction of major adverse cardiovascular events in adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors.

David L. Dunner is a psychiatrist in Washington, United States, who has conducted pioneering research into mood disorders, anxiety disorders and their treatment. He has authored or co-authored more than 250 articles and more than 10 books.

<span class="mw-page-title-main">Study 329</span> Scientific article

Study 329 was a clinical trial which was conducted in North America from 1994 to 1998 to study the efficacy of paroxetine, an SSRI anti-depressant, in treating 12- to 18-year-olds diagnosed with major depressive disorder. Led by Martin Keller, then professor of psychiatry at Brown University, and funded by the British pharmaceutical company SmithKline Beecham—known since 2000 as GlaxoSmithKline (GSK)—the study compared paroxetine with imipramine, a tricyclic antidepressant, and placebo. SmithKline Beecham had released paroxetine in 1991, marketing it as Paxil in North America and Seroxat in the UK. The drug attracted sales of $11.7 billion in the United States alone from 1997 to 2006, including $2.12 billion in 2002, the year before it lost its patent.

Bamlanivimab is a monoclonal antibody developed by AbCellera Biologics and Eli Lilly as a treatment for COVID-19. The medication was granted an emergency use authorization (EUA) by the US Food and Drug Administration (FDA) in November 2020, and the EUA was revoked in April 2021.

References

  1. ↑ "30 deadliest mass Shootings in U.S. history". KDVR . June 12, 2016. Retrieved October 31, 2016.
  2. 1 2 3 4 5 Cornwell, John (February 1, 1998). The Power to Harm. Penguin Books. ISBN   9781101199527.
  3. ↑ Kleber, John E. (January 13, 2015). The Encyclopedia of Louisville. University Press of Kentucky. ISBN   9780813149745.
  4. 1 2 3 4 5 6 7 8 9 10 11 Smothers, Ronald (September 17, 1989). "Survivors of Shooting and Gunman's Relatives Ponder Sad Riddles". The New York Times . Retrieved September 15, 2019.
  5. 1 2 Ames, Mark (November 16, 2005). Going Postal: Rage, Murder, and Rebellion: From Reagan's Workplaces to Clinton's Columbine and Beyond . Soft Skull Press. ISBN   9781932360820.
  6. 1 2 3 4 5 6 7 8 9 10 11 12 Kelleher, Michael D. (January 28, 1997). Profiling the Lethal Employee. Bloomsbury Academic. ISBN   9780275957568.
  7. 1 2 Smothers, Ronald (September 16, 1989). "Disturbed Past of Killer of 7 Is Unraveled". The New York Times .
  8. ↑ "'Let them Eat Prozac' Website - The Trials - Fentress et al v Shea Communications et al. Trial Background".
  9. 1 2 3 4 "Records show killer having mental problems". The Victoria Advocate . September 24, 1989. p. 20.
  10. ↑ Jarvik, Elaine (September 16, 1989). "Unresolved traumas lead to tragedies, psychotherapist says". Deseret News . Archived from the original on January 13, 2012.
  11. ↑ "What About Prozac?/Texas Rules/Welfare for the Wealthy". 60 Minutes . Season 24. Episode 7. October 27, 1991. CBS.
  12. ↑ "At Least Eight Killed in Kentucky Shooting". The Victoria Advocate . September 15, 1989. p. 1.
  13. ↑ Deposition of Dr. Lee A. Coleman
  14. 1 2 Zitrin, Richard; Langford, Carol M. (September 5, 2000). The Moral Compass of the American Lawyer: Truth, Justice, Power and Greed. Ballantine Books. ISBN   9780449006719.
  15. ↑ "Papers indicate firm knew possible Prozac suicide risk". CNN . January 3, 2005.
  16. 1 2 Maslin, Janet (June 29, 2000). "Books of the Times; Exploring a Dark Side of Depression Remedies". The New York Times . Retrieved May 24, 2010. ... the facts were carefully manipulated, a secret settlement was made between plaintiffs and the drug company even as the trial continued, and Prozac avoided a warning label about possibly violent or suicidal behavior.
  17. 1 2 AT LILLY, THE SIDE-EFFECTS OF ORAFLEX, New York Times, Aug 15, 19882.
  18. 1 2 3 Potter v Eli Lilly and Co. 926 S.W.2d 449 (1996)
  19. ↑ "Papers indicate firm knew possible Prozac suicide risk". CNN . January 3, 2005.
  20. ↑ "Prozac Litigation - Link to Suicide, Birth Defects & Class Action". Drugwatch.com. Retrieved 2024-12-07.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.